|
Category: preservatives
US / EU / FDA / JECFA / FEMA / FLAVIS / Scholar / Patent Information:
Physical Properties:
| Appearance: | pale reddish viscous liquid (est) |
| Assay: | 95.00 to 100.00 %
|
| Food Chemicals Codex Listed: | No |
| Specific Gravity: | 1.19500 to 1.25000 @ 25.00 °C.
|
| Pounds per Gallon - (est).: | 9.944 to 10.401
|
| Refractive Index: | 1.50850 to 1.51150 @ 20.00 °C.
|
| Boiling Point: | 335.40 °C. @ 760.00 mm Hg (est)
|
| Vapor Pressure: | 0.000008 mmHg @ 25.00 °C. (est) |
| Flash Point: | > 230.00 °F. TCC ( > 110.00 °C. )
|
| logP (o/w): | -1.108 (est) |
| Soluble in: |
| | alcohol | | | glycerin | | | propylene glycol | | | water |
Organoleptic Properties:
Odor Description:
| dull pleasent sweet |
| |
| Odor and/or flavor descriptions from others (if found). |
| |
| |
Cosmetic Information:
Suppliers:
Safety Information:
| |
| Hazards identification |
| |
| Classification of the substance or mixture |
| GHS Classification in accordance with 29 CFR 1910 (OSHA HCS) |
| None found. |
| GHS Label elements, including precautionary statements |
| |
| Pictogram | |
| |
| Hazard statement(s) |
| None found. |
| Precautionary statement(s) |
| None found. |
| Oral/Parenteral Toxicity: |
|
Not determined
|
| Dermal Toxicity: |
|
Not determined
|
| Inhalation Toxicity: |
|
Not determined
|
Safety in Use Information:
| Category: | preservatives |
| Recommendation for triethanolamine salicylate usage levels up to: | | | not for fragrance use.
|
| |
| Recommendation for triethanolamine salicylate flavor usage levels up to: |
| | not for flavor use.
|
Safety References:
References:
| | 2-[bis(2-hydroxyethyl)amino]ethanol;2-hydroxybenzoic acid |
| NIST Chemistry WebBook: | Search Inchi |
| Pubchem (cid): | 25213 |
| Pubchem (sid): | 135071827 |
Other Information:
Potential Blenders and core components note
Potential Uses:
Occurrence (nature, food, other): note
Synonyms:
| | filtrosol B | | 2- | hydroxybenzoic acid, 2-[bis(2-hydroxyethyl)amino]ethan-1-ol | | 2- | hydroxybenzoic acid, compd. with 2,2',2''-nitrilotris(ethanol) (1:1) | | 2-[bis(2- | hydroxyethyl)amino]ethanol;2-hydroxybenzoic acid | | | mobisyl | | | salicylic acid compound with 2,2',2''-nitrilotriethanol (1:1) | | | salicylic acid, compound with 2,2',2''-nitrilotriethanol (1:1) | | | TEA-salicylate | | | triethanolamine salicylate | | | trolamine salicylate |
Articles:
| PubMed: | Safety assessment of Salicylic Acid, Butyloctyl Salicylate, Calcium Salicylate, C12-15 Alkyl Salicylate, Capryloyl Salicylic Acid, Hexyldodecyl Salicylate, Isocetyl Salicylate, Isodecyl Salicylate, Magnesium Salicylate, MEA-Salicylate, Ethylhexyl Salicylate, Potassium Salicylate, Methyl Salicylate, Myristyl Salicylate, Sodium Salicylate, TEA-Salicylate, and Tridecyl Salicylate. |
| PubMed: | Self promotion of deep tissue penetration and distribution of methylsalicylate after topical application. |
| PubMed: | Topical penetration of commercial salicylate esters and salts using human isolated skin and clinical microdialysis studies. |
| PubMed: | Percutaneous absorption of salicylates from some commercially available topical products containing methyl salicylate or salicylate salts in rats. |
| PubMed: | Assessment of triethanolamine salicylate release from the dermatological bases and the commercial products. |
| PubMed: | Absorption of labeled triethanolamine salicylate in human and canine knee joints. II. |
| PubMed: | INFRARED ABSORPTION RATIO METHOD FOR DETERMINATION OF TRIETHANOLAMINE SALICYLATE IN OINTMENT. |
|